FTC: MDS Must Sell Arcturus Business to Life Technologies to Proceed with Danaher Deal

The FTC provided provisional approval of Danaher's purchase of MDS Analytical Technologies. However, it is requiring MDS to sell its laser microdissection business to Life Technologies to alleviate the agency's competition concerns.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.